Aspen Offloads Six In South Africa With Debt Still A Priority
South African Firm Continues To ‘Reshape And Refine Portfolio’
South Africa’s Aspen Pharmacare is continuing along the path of offloading assets that no longer fit into its strategy, using the proceeds to pay off its substantial debt pile and reinvest in areas of greater strategic focus. Half-a-dozen products currently offered in its local market are now on their way to Switzerland’s Acino.
You may also be interested in...
Deal Watch: Merck Looks To Technology Platform Partners For Cytokine Agonist Discovery, Drug Delivery
Plus deals involving Moderna/Metagenomi, Agomab/Origo, Selecta/Ginkgo, Teva/MODAG, Boehringer Ingelheim/Thoeris and X-Chem/ComInnex/Glamorous AI.
EU Business Round-Up: BioGaia Seeks Bigger Slice Of UK, Acino Gets Middle East Backers, Boots Moves Into Advertising
The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.
ANI pharma strengthens leadership team by adding three new executives to accelerate future growth. While Coherus and Xbrane appoint new chief financial officers, Lupin and Beximco hire new independent directors. Sandoz is certified “Global Top Employer 2021” yet again by Top Employers Institute.